Australian Health Practitioner Regulation Agency (AHPRA) / National Boards

Medical Board Consultations

 

Regulation of Cosmetic Procedures

ASPS supports Option 3 (three) outlined in the Medical Board’s Consultation Paper and Regulation Impact Statement, that is, to strengthen current guidance for medical practitioners providing cosmetic medical and surgical procedures through new, practice-specific guidelines that clearly articulate the Board’s expectations of medical practitioners.

Download a copy of our submission (May 2015) to the Medical Board in response to its Public consultation paper and Regulation Impact Statement – Registered medical practitioners who provide cosmetic medical and surgical procedures (March 2015).

 

Specialist Title

In consultation with the Medical Board of Australia and the Australian Health Practitioner and Regulation Agency (AHPRA), ASPS determined that the protected title for fully qualified and accredited plastic surgeons shall be “Specialist Plastic Surgeon”. The title denotes that:

  • The surgeon is accredited by the Australian Medical Council in the specialty of Plastic Surgery and;
  • Registered under National Law in that specialty.

Download a copy of our submission to the Medical Board on the establishment of specialty titles (October 2010). In November 2012, ASPS wrote to the Medical Board of Australia, requesting a review of specialty titles and the way in which information is presented to patients. Download a copy of our letter (November 2012).

Related Advocacy

May 2015: On 28 April 2015 the Federal Court heard the ACCS’ application in relation to its application to recognise the specialty of Cosmetic Medical Practice. In May, the Court dismissed the application and ordered the ACCS to pay costs. Read the Federal Court ruling.

October 2013: ASPS wrote to Health Engine regarding the correct classification of medical practitioners in its online health directory service. Read our letter.

 

Nursing and Midwifery Board Consultation

November 2012: ASPS and ASAPS made a joint submission to AHPRA’s nursing and midwifery board regarding nurse administration of S4 medicines. Read the joint submission.

AHPRA’s consultation paper (Sept 2013) is available to download and review.

 

Related Content